Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
01/05/2023 | Kintara Therapeutics, Inc. | DMPI | Acquisition (by will) | Common Stock, par value $0.001 per share | 363 | $0.00 | $0 | | 01/05/2023 |
08/01/2022 | Kintara Therapeutics, Inc. | DMPI | Grant | Common Stock | 240.1k | $0.00 | $0 | | 08/01/2022 |
08/01/2022 | Kintara Therapeutics, Inc. | DMPI | Grant | Option (right to buy) | 720.3k | $0.18 | $126.5k | | 08/01/2022 |
06/30/2021 | Cell Source, Inc. | CLCS | Other (acquisition) | Common Stock | 3k | $0.75 | $2.2k | | 06/30/2021 |
04/29/2021 | Kintara Therapeutics, Inc. | DMPI | Conversion | Common Stock | 750 | $0.00 | $0 | | 04/29/2021 |
04/29/2021 | Kintara Therapeutics, Inc. | DMPI | Conversion | Series B Convertible Preferred Stock | 3k | $0.00 | $0 | | 04/29/2021 |
04/29/2021 | Kintara Therapeutics, Inc. | DMPI | Other (acquisition) | Common Stock | 6 | $0.00 | $0 | | 04/29/2021 |
03/31/2021 | Kintara Therapeutics, Inc. | DMPI | Other (acquisition) | Common Stock | 17 | $0.00 | $0 | | 03/31/2021 |
12/31/2020 | Kintara Therapeutics, Inc. | DMPI | Other (acquisition) | Common Stock | 17 | $0.00 | $0 | | 12/31/2020 |
12/29/2020 | Cell Source, Inc. | CLCS | Other (acquisition) | Common Stock | 3k | $0.75 | $2.3k | | 02/13/2019 |
09/30/2020 | Kintara Therapeutics, Inc. | DMPI | Other (acquisition) | Common Stock | 17 | $0.00 | $0 | | 09/30/2020 |
09/22/2020 | Kintara Therapeutics, Inc. | DMPI | Grant | Options (Right to Buy) | 60k | $1.36 | $81.3k | | 09/22/2020 |
09/15/2020 | Kintara Therapeutics, Inc. | DMPI | Grant | Options (Right to Buy) | 87.4k | $1.70 | $148.6k | | 09/15/2020 |
08/19/2020 | Cell Source, Inc. | CLCS | Grant | Director Stock Option (Right to Buy) | 450k | $0.75 | $337.5k | | 02/13/2019 |
06/30/2020 | Cell Source, Inc. | CLCS | Other (acquisition) | Common Stock | 3k | $0.75 | $2.2k | | 02/13/2019 |
06/30/2020 | Kintara Therapeutics, Inc. | DMPI | Other (acquisition) | Common Stock | 17 | $0.00 | $0 | | 06/26/2020 |
06/26/2020 | Kintara Therapeutics, Inc. | DMPI | Grant | Options (Right to Buy) | 52.8k | $0.61 | $32.2k | | 06/26/2020 |
06/26/2020 | Kintara Therapeutics, Inc. | DMPI | Grant | Options (Right to Buy) | 250k | $0.74 | $183.8k | | 06/26/2020 |
03/31/2020 | Kintara Therapeutics, Inc. | DMPI | Other (acquisition) | Common Stock | 17 | $0.00 | $0 | | 03/31/2020 |
12/31/2019 | Cell Source, Inc. | CLCS | Other (acquisition) | Common Stock | 5.9k | $0.75 | $4.5k | | 02/13/2019 |
12/31/2019 | Kintara Therapeutics, Inc. | DMPI | Other (acquisition) | Common Stock | 17 | $0.00 | $0 | | 12/27/2019 |
12/27/2019 | Kintara Therapeutics, Inc. | DMPI | Gift | Common Stock | 7.5k | $0.00 | $0 | | 12/27/2019 |
11/12/2019 | Kintara Therapeutics, Inc. | DMPI | Grant | Options (Right to Buy) | 250k | $0.74 | $183.8k | | 11/12/2019 |
11/12/2019 | Kintara Therapeutics, Inc. | DMPI | Grant | Options (Right to Buy) | 250k | $0.74 | $183.8k | | 11/12/2019 |
09/30/2019 | Kintara Therapeutics, Inc. | DMPI | Other (acquisition) | Common Stock | 17 | $0.00 | $0 | | 09/30/2019 |
09/05/2019 | Kintara Therapeutics, Inc. | DMPI | Grant | Options (Right to Buy) | 47.2k | $0.61 | $28.8k | | 09/05/2019 |
09/05/2019 | Kintara Therapeutics, Inc. | DMPI | Grant | Options (Right to Buy) | 52.8k | $0.61 | $32.2k | | 09/05/2019 |
06/28/2019 | Kintara Therapeutics, Inc. | DMPI | Other (acquisition) | Common Stock | 17 | $0.00 | $0 | | 06/28/2019 |
03/29/2019 | Kintara Therapeutics, Inc. | DMPI | Other (acquisition) | Common Stock | 169 | $0.49 | $82.8 | | 03/29/2019 |
02/13/2019 | Cell Source, Inc. | CLCS | Grant | Series A Convertible Preferred Stock | 6.7k | $0.75 | $5k | | 02/13/2019 |
12/31/2018 | Kintara Therapeutics, Inc. | DMPI | Other (acquisition) | Common Stock | 169 | $0.34 | $57.8 | | 12/21/2018 |
12/21/2018 | Kintara Therapeutics, Inc. | DMPI | Gift | Common Stock | 85k | $0.00 | $0 | | 12/21/2018 |
09/28/2018 | Kintara Therapeutics, Inc. | DMPI | Other (acquisition) | Common Stock | 169 | $3.20 | $540.8 | | 09/28/2018 |
06/29/2018 | Kintara Therapeutics, Inc. | DMPI | Other (acquisition) | Common Stock | 169 | $3.20 | $540.8 | | 06/29/2018 |
03/30/2018 | Kintara Therapeutics, Inc. | DMPI | Other (acquisition) | Common Stock | 169 | $3.20 | $540.8 | | 03/30/2018 |
|